Related Experiment Video
Updated: Feb 28, 2026

07:17
Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions
Published on: January 19, 2024
3.0K
Current best medical practices survey in vagus nerve stimulation programming
Debra T Moore-Hill1,2, Molly Butler1, Danielle L Weiss1,2
1Medical College of Georgia at Augusta University, Augusta, GA, USA.
Epilepsy & Behavior Reports
|February 27, 2026
Summary
Practices for Vagal Nerve Stimulator (VNS) programming vary significantly among epilepsy specialists, indicating a gap between guidelines and real-world application for drug-resistant epilepsy (DRE) patients.
Area of Science:
- Neurology
- Epilepsy Management
- Medical Device Technology
Background:
- Vagal Nerve Stimulator (VNS) Therapy offers programmable stimulation modes (Normal Mode, Automatic Stimulation, On-Demand Magnet Mode) and duty cycles.
- Existing VNS therapy guidelines may not fully align with current clinical practices.
- Understanding real-world VNS programming is crucial for optimizing patient outcomes in drug-resistant epilepsy (DRE).
Purpose of the Study:
- To identify and analyze current best medical practices in VNS programming among epilepsy practitioners.
- To highlight variations and potential discrepancies between established VNS guidelines and actual clinical application.
- To provide insights into optimal VNS therapy settings for improved patient outcomes.
Main Methods:
- An anonymous, IRB-approved online survey was distributed to VNS therapy practitioners at the American Epilepsy Society Meeting.
- Survey participants included epileptologists primarily practicing in the US, reporting on VNS programming for up to 50 patients.
- Data collected focused on programming parameters for Normal Mode (NM), Automatic Stimulation (AS), and Duty Cycle (DC), alongside response timelines.
Main Results:
- Significant variability was observed in the programming of NM, AS, and DC parameters.
- Median initial and maximum NM output currents were 1-1.25 mA and 2-2.5 mA, respectively.
- Most practitioners programmed AS current higher than NM, with specific heart-rate thresholds reported by a subset; median final DC target was 35%.
Conclusions:
- This study reveals considerable variability in VNS programming practices among epilepsy specialists.
- The findings underscore a gap between VNS therapy guidelines and their practical implementation in clinical settings.
- Insights into current practices can guide optimization of VNS therapy settings and enhance outcomes for DRE patients.

